!!Marek Sanak - Selected Publications
\\
1. Wawrzyniak, P.;  Krawczyk, K.;  Acharya, S.;  Tan, G.;  Wawrzyniak, M.;  Karouzakis, E.;  Dreher, A.;  Jakiela, B.;  Altunbulakli, C.;  Sanak, M.;  O‘Mahony, L.;  Nadeau, K.; Akdis, C. A., Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma. Allergy: European Journal of Allergy and Clinical Immunology 2021, 76 (6), 1864-1868. \\
\\
2. Tyrak, K. E.;  Pajdzik, K.;  Jakieła, B.;  Kupryś-Lipińska, I.;  Ćmiel, A.;  Kacorzyk, R.;  Trąd, G.;  Kuna, P.;  Sanak, M.; Mastalerz, L., Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease. Clinical and Experimental Allergy 2021, 51 (8), 1046-1056. \\
\\
3. Siemińska, I.;  Węglarczyk, K.;  Surmiak, M.;  Kurowska-Baran, D.;  Sanak, M.;  Siedlar, M.; Baran, J., Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions. Frontiers in Immunology 2021, 12.\\
\\
4. Karska-Basta, I.;  Pociej-Marciak, W.;  Chrząszcz, M.;  Kubicka-Trząska, A.;  Romanowska-Dixon, B.; Sanak, M., Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy. Acta Ophthalmologica 2021, 99 (2), e222-e231.\\
\\
5. Pancer, K.;  Milewska, A.;  Owczarek, K.;  Dabrowska, A.;  Kowalski, M.;  Labaj, P.;  Branicki, W.;  Sanak, M.; Pyrc, K., The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans. PLoS Pathogens 2020, 16 (12). \\
\\
6. Milewska, A.;  Kula-Pacurar, A.;  Wadas, J.;  Suder, A.;  Szczepanski, A.;  Dabrowska, A.;  Owczarek, K.;  Marcello, A.;  Ochman, M.;  Stacel, T.;  Rajfur, Z.;  Sanak, M.;  Labaj, P.;  Branicki, W.; Pyrc, K., Replication of severe acute respiratory syndrome coronavirus 2 in human respiratory epithelium. Journal of Virology 2020, 94 (15). \\
\\
7. Bartoszewski, R.;  Dabrowski, M.;  Jakiela, B.;  Matalon, S.;  Harrod, K. S.;  Sanak, M.; Collawn, J. F., SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs. American Journal of Physiology - Lung Cellular and Molecular Physiology 2020, 319 (3), L444-L455. \\
\\
8. Mastalerz, L.;  Tyrak, K. E.;  Ignacak, M.;  Konduracka, E.;  Mejza, F.;  Ćmiel, A.;  Buczek, M.;  Kot, A.;  Oleś, K.; Sanak, M., Prostaglandin E2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin. Allergy: European Journal of Allergy and Clinical Immunology 2019, 74 (5), 922-932. \\
\\
9. Michalik, M.;  Wójcik-Pszczoła, K.;  Paw, M.;  Wnuk, D.;  Koczurkiewicz, P.;  Sanak, M.;  Pękala, E.; Madeja, Z., Fibroblast-to-myofibroblast transition in bronchial asthma. Cellular and Molecular Life Sciences 2018, 75 (21), 3943-3961. \\
\\
10. Sierzega, M.;  Kaczor, M.;  Kolodziejczyk, P.;  Kulig, J.;  Sanak, M.; Richter, P., Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: The importance of MIR-21 and MIR-331. British Journal of Cancer 2017, 117 (2), 266-273.\\ \\[{ALLOW view All}][{ALLOW edit msanak}][{ALLOW upload msanak}][{ALLOW comment All}]
[{ALLOW view All}][{ALLOW edit msanak}][{ALLOW upload msanak}][{ALLOW comment All}]